Latest Quarter
Q1 FY2025ended 2026-03-31 · filed 2026-05-08
$965.1M
$14.44M
$28.53M
$0.29
$478.38M
$2.36B
$800.27M
$979.76M
What this quarter tells us
For Q1 FY2025 (ended March 31, 2026), Astrana Health reported revenue of $965.1 million, up 55.6% year-over-year. Net income was $14.4 million, a 115.7% increase, while diluted EPS rose 107.1% to $0.29. Operating income grew 38.6% to $28.5 million. The company had $478.4 million in cash, $800.3 million in equity, and $979.8 million in long-term debt.
- •Revenue surged 55.6% YoY to $965.1M.
- •Net income more than doubled, up 115.7% to $14.4M.
- •Diluted EPS increased 107.1% to $0.29.
- •Operating income grew 38.6% to $28.5M.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.